New Study Shows Covid Vaccines Were Associated With Significant + Ongoing Menstrual Bleeding | New Zealand Data Revealed A 90% Fully Vaccinated Population & Skyrocketing Covid Cases | Myocarditis+mRNA
Have you seen the newest data on Covid? Specifically, recently released public health and covid vaccine data made available over the past 48 hours? Surely not, as the aforementioned is not being widely reported, however, below it will be.
To be specific, just the other day, a new study in Science illuminated a strong association between women who received Covid vaccination and heavy, irregular menstrual bleeding. Next, recently published public health data from New Zealand explained how Covid cases skyrocketed despite a nearly 90% full vaccinated population. Finally, another study released in the BMJ (British Medical Journal) shed new light on the risks, and mechanisms of myocarditis after Covid vaccination.
All and all, the data has been summarized for you below but please read through the sources. Finally, make sure to share this post with EVERYONE YOU KNOW by clicking immediately below so this information gets out fast.
A new study posted in Science exploring the effects of COVID vaccines on menstruation found that of 39k non-menstruating respondents, 66% of post-menopausal women, 71% utilizing contraceptives, and 39% of those on gender affirming hormones reported significant breakthrough bleeding within 14 day after 1st or 2nd dose. All the aforementioned data suggests that Covid vaccines were associated with significant inflammatory change.
https://www.science.org/doi/10.1126/sciadv.abm7201
Despite “red traffic light” COVID restrictions in New Zealand involving compulsory public mask wearing, vaccine passports and social distancing that began late January 2022, plus a nearly 90% fully vaccinated population, cases continued to skyrocket.
Stringent Covid restrictions never work.
https://ourworldindata.org/coronavirus
https://coronavirus.jhu.edu/map.html
A new meta-analysis of 46 studies on myocarditis post mRNA vaccination revealed a ~1/7K risk in males aged 12-29 after dose 2 within 21 days especially with Moderna & likely brought on by autoimmune molecular mimicry, where all age groups experienced 84% hospitalization
In other words, that means 1 in every 7K males aged 12-29 post 2nd dose risked hospitalized from myocarditis which opens up the door for LGE and is therefore associated with 6X increased odds of heart failure death even after recovery from acute myocarditis (5.68, 95% CI: 1.04 to 31.07) within 3 years
FDA approval of Paxlovid was mainly based on an unvaccinated cohort, yet nearly 80% of Americans received at least 1 dose. Sadly, now access is being expanded by allowing pharmacists prescribe the drug to patients right at the counter- no MD needed.
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-additional-phase-23-study-results
LETS CONNECT: